Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
RAFT Polymer Design for mRNA Delivery
2026-09-25
This study combines combinatorial RAFT polymer synthesis, high-throughput biological screening, and machine learning to identify tertiary amine-containing methacrylate polymers for mRNA delivery. Its lead materials outperformed PEI and Lipofectamine in the reported assays, while the computational analysis highlighted the value of relating polymer and polyplex properties to uptake, toxicity, and expression outcomes.
-
Docosahexaenoic Acid (DHA) Assay Workflow
2026-09-25
A practical guide to using Docosahexaenoic Acid (DHA) in cell viability, proliferation, and cytotoxicity studies. Learn how SKU C4188’s formulation details inform solvent controls, dose-finding, and cautious interpretation of neuroprotection research.
-
GSH and GSSG Assay Kit for Tumor Hypoxia
2026-09-24
Track reduced and oxidized glutathione to add a measurable redox layer to studies of hypoxia-driven tumor immunometabolism. The GSH and GSSG Assay Kit supports total glutathione and selective GSSG measurements, helping distinguish a change in glutathione abundance from a shift in redox balance.
-
Solanesol (B8776): Handling and Assay Workflow
2026-09-24
Solanesol (B8776) provides a defined polyisoprenoid alcohol for research workflows that need a hydrophobic compound, with DMSO as the reported compatible solvent. It is unsuitable for water- or ethanol-based stocks; use fresh solutions and treat assay outcomes as experimental questions rather than established effects.
-
CDK9 inhibitor A3294: Practical Research Workflow
2026-09-23
CDK9 inhibitor A3294 is a selective serine/threonine kinase inhibitor for investigating CDK9-dependent transcription elongation and defined HIV-1 assays. Use it for controlled biochemical or cell-based workflows, not as a pan-CDK reagent or evidence of therapeutic activity; its reported cell-viability and HIV findings apply only to the conditions described in the product dossier.
-
Polygodial: Designing Better TRPA1 Assays
2026-09-23
Polygodial is a research-grade TRPA1 channel activator for examining calcium-dependent sensory signaling. This article presents an evidence-driven assay framework that separates channel engagement from NFAT, TSLP, and inflammatory readouts.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-09-22
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer cell proliferation, and metabolic responses. It is suited to preclinical mechanistic workflows, but its DMSO-only solubility and limited clinical benefit make it unsuitable for water-based formulations or clinical efficacy prediction.
-
Fludarabine Workflows for Oncology Research
2026-09-22
Build reproducible Fludarabine experiments around DNA synthesis inhibition, cell-cycle analysis, and apoptosis readouts in leukemia and multiple myeloma models. A paired immune-assay strategy also helps distinguish direct cytotoxicity from exploratory effects on tumor antigen presentation.
-
3X FLAG Peptide for Mechanistic Cancer Assays
2026-09-21
The 3X (DYKDDDDK) Peptide can do more than improve FLAG detection: it can help build a controlled assay architecture for testing the MAZ–BCKDK–G6PD metabolic axis in triple-negative breast cancer. This guide connects epitope-tag chemistry, interaction validation, purification, and metal-aware assay design.
-
FLAG tag Strategy for VPS13C Mechanistic Studies
2026-09-21
A translational framework for using the FLAG tag Peptide (DYKDDDDK) to improve VPS13C purification, detection, and conformational-state analysis while preserving experimental discipline around calmodulin, calcium signaling, and lipid-transfer regulation.
-
Human Organellar SPFH Complexes: Cryo-EM Architectures
2026-09-20
This study defines the architectures of two previously unresolved human organellar SPFH assemblies using single-particle cryo-EM. It shows that Erlin1/2 and PHB1/2 form distinct heterodimeric cages with different stoichiometries, while preserving broader principles of SPFH ring organization and conformational flexibility.
-
Mtb Reprograms ATP6V1E1 Phosphorylation via BMX
2026-09-19
A 2026 Nature Communications study identifies the Mtb secreted acyltransferase Chp2/Rv1184 as a regulator of host lysosomal acidification. By promoting BMX-dependent phosphorylation of ATP6V1E1, Chp2 disrupts V-ATPase assembly, weakens phagosomal acidification, and supports bacterial persistence in macrophages and mice.
-
3X (DYKDDDDK) Peptide: FANCJ Workflow Guide
2026-09-18
The 3X (DYKDDDDK) Peptide supports sensitive capture, elution, and verification of recombinant proteins, with particular value in demanding FANCJ helicase and structural-biology workflows. This guide connects FLAG-tagged protein handling with metal-aware immunodetection, assay controls, and practical troubleshooting.
-
Camostat Mesilate for Reliable Cell Assays
2026-09-18
Camostat Mesilate (SKU B2082) offers a defined, soluble trypsin-like protease inhibitor for interpreting viability, proliferation, cytotoxicity, ENaC, plasmin, and TGF-β experiments. This scenario-based guide explains formulation, dose selection, controls, pathway-specific interpretation, and practical vendor evaluation.
-
7ACC2: Mapping Lactate Flux in Tumor Models
2026-09-17
7ACC2 is a potent monocarboxylate transporter 1 inhibitor for resolving lactate and pyruvate transport in cancer metabolism research. This assay-centered guide explains how to distinguish direct transport effects from broader immunometabolic consequences and radiosensitization.